Protective potential of glimepiride and Nerium oleander extract on lipid profile, body growth rate, and renal function in streptozotocin-induced diabetic rats

Turkish Journal of Biology

Volumn 31, Issue 2, 2007, Pages 95-102

  Yassin, Maged M ^a   Mwafy, Saleh N ^b  

^a ISLAMIC UNIVERSITY OF GAZA   (Palestine)

^b AL AZHAR UNIVERSITY   (Palestine)

Author keywords

Diabetes rats; Glimepiride; Growth rate; Kidney; Lipids; Nerium oleander; Protection

Indexed keywords

ANIMALIA; NERIUM; NERIUM OLEANDER; RATTUS;

EID: 34347357555     PISSN: 13000152     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. World Health Organization, Diabetes Programme, Department of Chronic Diseases and Health Promotion; Facts and Figures sheet-Diabetes, Geneva, Switzerland 2006.
2. th ed. Lea & Febiger, Philadelphia. Baltimore, Hong Kong, London, Monish, Sydney, Tokyo; 1994: pp. 193-200.
3. Uusitupa MI, Niskanen LK, Siitonen O et al. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36: 1175-1184, 1993.
4. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 536-546, 2001.
5. El-Agouza IM, Rawy AM, Saad AM et al. Effect of sulfur containing amino acids and insulin injection on streptozotocin diabetic rats. J Drug Res Egypt 23: 213-224, 2000.
6. Ravi K, Rajasekaran S, Subramanian S. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats. Food Chem Toxicol 43: 1433-1439, 2005.
7. Bolkent S, Yanardag R, Tunali S. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 70: 103-109, 2005.
8. Gawronska-Szklarz B, Musial DH, Pawlik A et al. Effect of experimental diabetes on pharmacokinetic parameters of lidocaine and MEGX in rats. Pol J Pharmacol 55: 619-624, 2003.
9. Yassin MM, Ashour AA, Elyazji NR. Alterations in body weight, protein profile, non-protein nitrogen constituents and kidney structure in diabetic rats under glibenclamide treatment. J Islam Univ Gaza 12: 65-82, 2004.
10. Tesch GH and Nikolic-Paterson DJ. Recent Insights into Experimental Mouse Models of Diabetic Nephropathy. Nephron Exp Nephrol 104: 57-62, 2006.
11. Bando K and Yamada Y. Glimepiride (Amaryl): a review of its pharmacological and clinical profile. Nippon Yakurigaku Zasshi 118: 59-67, 2001.
12. Sato J, Ohsawa I, Oshida Y et al. Effects of glimepiride on in vivo insulin action in normal and diabetic rats. Diabetes Res Clin Pract 22: 3-9, 1993.
13. American Cancer Society's Guide: American cancer society's guide to complementary and alternative methods, USA, 2002.
14. Haeba MH, Mohamed AI, Mehdi AW et al. Toxicity of Nerium oleander leaf extract in mice. J Environ Biol 23: 231-237, 2002.
15. Mythili MD, Vyas R, Akila G et al. Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microsc Res Tech 63: 274-281, 2004.
16. Nieszner E, Posa I, Pogatsa G et al. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infraction with and without ischemic preconditioning in rabbits. Exp Clin Endocrinol Diabetes 110: 212-218, 2002.
17. Hosseinzadeh H, HaddadKhodaparast MH, Shokohizadeh H. Antihyperglycemic effect of Salvia leriifolia leaf and seed extract in mice. Irn J Med Sci 23: 74-80, 1998.
18. Adam SE, Al-Yahya MA, Al-Farhan AH. Acute toxicity of various oral doses of dried Nerium oleander leaves in sheep. Am J Chin Med 29: 525-532, 2001.
19. Fossati P and Principe L. Triglycerides enzymatic colorimetric test. Clin Chem 28: 2077, 1982.
20. Richmond W. Preparation and properties of cholesterol oxidase from Nocarddia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19: 1350-1356, 1973.
21. Fawcett JK and Scott JE. A rapid and precise method for the determination of urea. J Clin Pathol 13: 156-159, 1960.
22. Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2- hydroxybenzenesulfonic acid/ 4-aminophenazone chromogenic system in direct enzymatic assay of uric acid in serum and urine. Clin Chem 26: 227-231, 1980.
23. Bartels H, Bohmer M, Heierli C. Serum creatinine determination without protein precipitation. Clin Chem Acta 37: 193-197, 1972.
24. Yassin MM and Mwafy SN. Influence of glimepiride and Nerium oleander extract on insulin, glucose levels and some liver enzymes activities in streptozotocin-induced diabetic rats. Acta Physiol Hung In publication 2006.
25. Tunali S and Yanardag R. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats. Pharmacol Res 53: 271-277, 2006.
26. Annida B and Stanely Mainzen Prince P. Supplementation of fenugreek leaves lower lipid profile in streptozotocin-induced diabetic rats. J Med Food 7:153-156, 2004.
27. Pushparaj P, Tan CH, Tan BKH. Effects of Averrhoe bilimli leaf extract on blood glucose and lipids in streptozotocin diabetic rats. J Ethnopharmacol 72: 69-76, 2000.
28. Bopanna KN, Kannan J, Sushma G et al. Antidiabetic and antihyperlipaemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian J Pharmacol 29: 162-167, 1997.
29. Pepato MT, Keller AM, Baviera AM et al. Anti-diabetic activity of Bauhinia forficata decoction in streptozotocin-diabetic rats. J Ethnopharmacol 81: 191-197, 2002.
30. Uchiyama S and Yamaguchi M. Oral administration of beta-cryptoxanthin prevents bone loss in streptozotocin-diabetic rats in vivo. Biol Pharm Bull 28:1766-1769, 2005.
31. Ozsoy-Sacan O, Yanardag R, Orak H et al. Effects of parsley (Petroselinum crispum) extract versus glibornuride on the liver of streptozotocin-induced diabetic rats. J Ethnopharmacol 104: 175-181, 2006.
32. Shukla UA, Chi EM, Lehr K. Glimepiride pharmacokinetics in obese versus non-obese diabetic patient. Ann Pharmacother 38: 30-35, 2004.
33. Ganong WF. Review of Medical Physiology. 17th ed. Lange Med Public USA; 1995.
34. Facchini F, Chen YDI, Hollenbeck CB et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266: 3008-3011, 1991.
35. Kecskemeti V, Bagi Z, Pacher P. New trends in the development of oral antidiabetic drugs. Curr Med Chem 9: 53-71, 2002.